Showing results (61-70 of 125) with videos related to
Sort By:
Pageof 13
World Journal of Surgery|July 20, 2006
Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resectionEtsuro Hatano, Iwao Ikai, Tatsuya Higashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2005
[Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer]Suguru Hasegawa, Shigemi Matsumoto, Kazuhiko Kawashima, et al.Bioorganic & Medicinal Chemistry Letters|December 2, 2008
Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonistsHideaki Fujii, Akio Watanabe, Toru Nemoto, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologiesShigeto Hirayama, Naohisa Wada, Naoya Kuroda, et al.Bioorganic & Medicinal Chemistry|September 9, 2015
Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chainRyo Nakajima, Naoshi Yamamoto, Shigeto Hirayama, et al.Chemmedchem|July 19, 2021
Identification of a Putative β-Arrestin Superagonist of the Growth Hormone Secretagogue Receptor (GHSR)Fumika Karaki, Tomoya Oki, Yuma Sakao, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2012
Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitorsAiko Nitta, Hideaki Fujii, Satoshi Sakami, et al.Journal of Clinical Medicine|January 26, 2024
SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted NeurogenesisTakashi Iwai, Rei Mishima, Shigeto Hirayama, et al.Behavioural Brain Research|May 14, 2011
The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsionsAkiyoshi Saitoh, Azusa Sugiyama, Toru Nemoto, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Rational drug design and synthesis of a selective opioid receptor antagonist on the basis of the accessory site conceptHideaki Fujii, Minoru Narita, Hirokazu Mizoguchi, et al.Pageof 13